Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05068908 · ClinicalTrials.gov registry record

Brain Connectivity Patterns in Chronic Temporomandibular Joint Disorders

A clinical trial of Chronic Pain and Temporomandibular Joint Disorders, sponsored by University of Minnesota.

Recruiting
Registry status
95
Enrollment target
1
Study location

NCT05068908: Recruiting study of Chronic Pain and Temporomandibular Joint Disorders, sponsored by University of Minnesota.

NCT05068908 is a study of Chronic Pain and Temporomandibular Joint Disorders that is actively recruiting participants, run by University of Minnesota. The registered enrollment target is 95 participants, below the 772-participant average among 301 other Chronic Pain trials with a reported enrollment target (88% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05068908, a study of Chronic Pain and Temporomandibular Joint Disorders, is actively recruiting participants, sponsored by University of Minnesota.

RECRUITING
Registry status
95 participants
Enrollment target
1
Study location

Study Summary

This study addresses the timely problem of painful temporomandibular disorders (TMD), the most common cause of orofacial pain second only to tooth pain. Findings from previous studies suggest that dysregulation of connectivity within specific brain circuits is part of chronic pain pathophysiology. This study will identify connectivity patterns within those brain circuits as potential signatures for pain- related disability in chronic TMD pain participants. New knowledge regarding these brain connectivity patterns is expected to be significant because it will support improved phenotyping of this heterogeneous participant population. It is also expected that this finding can potentially be extrapolated to other chronic pain conditions, such as back pain, migraine headache, and fibromyalgia that are frequently comorbid conditions in chronic TMD participants.

Primary Outcome

Multi-modal MRI data will be used to assess functional connectivity patterns within the thalamocortical brain circuit in chronic TMD pain participants and pain free controls. Functional connectivity will be reported as a unitless value. Neuroimaging will be conducted during Visit 3.

Study Locations (1)

Minnesota

  • University of Minnesota - Minneapolis

Trial Details

FieldValue
Enrollment Target 95 participants
Start Date 2022-03-02
Est. Completion 2026-08-31
University of Minnesota

966 total trials

What NCT05068908 shows while recruiting

NCT05068908 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 95 participants, a relatively small participant target, below the 772-participant average among 301 other Chronic Pain trials with a reported enrollment target (88% lower).

The record links to 3 conditions, with Chronic Pain appearing as the primary indexed condition, and to 0 interventions.

NCT05068908 reports a single indexed study location in Minnesota.

Frequently Asked Questions

What is clinical trial NCT05068908 about?

NCT05068908 is a clinical study titled "Brain Connectivity Patterns in Chronic Temporomandibular Joint Disorders". This study addresses the timely problem of painful temporomandibular disorders (TMD), the most common cause of orofacial pain second only to tooth pain. Findings from previous studies suggest that dysregulation of connectivity within specific brain circuits is part of chronic pain pathophysiology. T...

What is the current status of trial NCT05068908?

This trial is currently recruiting. The enrollment target is 95 participants. The study started on 2022-03-02. Estimated completion is 2026-08-31.

What conditions does trial NCT05068908 study?

This clinical trial studies the following conditions: Chronic Pain, Temporomandibular Joint Disorders, Temporomandibular Joint Pain.

Who is sponsoring clinical trial NCT05068908?

This trial is sponsored by University of Minnesota, which has 966 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05068908 being conducted?

This trial has 1 study location across Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Chronic Pain

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT05068908's enrollment target sits among peer trials

95 142nd of 301 higher than 159 of 301 other Chronic Pain trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Chronic Pain trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT03339128 · 95 participants · Phase 2

    Study to Explore the Therapeutic Effect of Eluxadoline in Treating Irritable Bowel Syndrome With Diarrhea in Children

  • NCT03509961 · 95 participants · Phase 2

    The EndRAD Trial: Eliminating Total Body Irradiation (TBI) for NGS-MRD Negative Children, Adolescents, and Young Adults With B-ALL

  • NCT03694756 · 95 participants · NA

    TMEM-MRI: A Pilot Feasibility Study of MRI for Imaging of TMEM in Patients With Operable Breast Cancer

  • NCT04542161 · 95 participants · Phase 2

    Assessment of N-Acetylcysteine as Therapy for Myalgic Encephalomyelitis/Chronic Fatigue Syndrome

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT05068908, the US trial registry maintained by the National Library of Medicine. NCT05068908 (small enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.